Rapid tracheal infusion of surfactant versus bolus instillation in rabbits: Effects on oxygenation, blood pressure and surfactant distribution

Neonatology

Volumn 69, Issue 2, 1996, Pages 119-127

  Segerer, Hugo ^a   Scheid, Annette ^a   Wagner, Mathias H ^a   Lekka, Marilena ^b   Obladen, Michael ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Animal model; Instillation method; Platelet activating factor; Pulmonary distribution; Respiratory distress syndrome; Surfactant substitution

Indexed keywords

BEPAFANT; LUNG SURFACTANT EXTRACT; MICROSPHERE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG DISTRIBUTION; INTRATRACHEAL DRUG ADMINISTRATION; LUNG LAVAGE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RABBIT; TISSUE OXYGENATION;

ANIMALS; AZEPINES; BLOOD PRESSURE; LUNG; OXYGEN; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION INHIBITORS; RABBITS; SURFACE-ACTIVE AGENTS; TISSUE DISTRIBUTION; TRACHEA; TRIAZOLES;

EID: 0029920569     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244286     Document Type: Article

References (36)

1. Fujiwara T, Maeta H, Chida S, Merita T, Watabc Y, Abe T: Artificial surfactant therapy in hyaline membrane disease. Lancet 1980;i:55-59.
2. Soll RF. McQueen MC: Respiratory distress syndrome; in Sinclair JC. Bracken MB (eds): Effective Care of the Newborn Infant. Oxford. Oxford University Press. 1992, pp 326-358.
3. Robertson B: Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant. Dev Pharmacol Ther 1989; 13:159-163.
4. Wang C. Barrow R. Cox CJ. Yang S. Herndon D: Influence of detergent aerosol on lung microvascular permeability. J Appl Physiol 1993:74: 1016-1023.
5. Lewis J. Ikegami M. Higuchi R. Jobe A. Absolom D: Nebulized vs. instilled exogenous surfactant in an adult lung injury model. J Appi Physiol 1991:71:1270-1276.
6. Lewis J. Ikegami M. Jobe A. Tabor B: Aerosolized surfactant treatment of preterm lambs. J Appi Physiol 1991:70:869-876.
7. Scgerer H. van Gelder W. Angencnt F. van Woerkens L. Curstedt T. Obladcn M. Lachmann B: Pulmonary distribution and efficacy of exogenous surfactant in lung-lavagcd rabbits are influenced by the instilla-tion technique. Pediatr Res 1993: 34:490-494.
8. Hellström-Westas L, Bell A, Skov L, Greisen G, Svcnningsen N: Cere-broclectrical depression following surfactant treatment in preterm neonates. Pediatrics 1992:89:643-647.
9. Skov L, Hellstrom-Westas L, Jacobsen T, Greisen G, Svenningsen N: Acute changes in cerebral oxygenation and cerebral blood volume in preterm infants during surfactant treatment. Neuropediatrics 1992: 23:126-130.
10. Skov L. Bell A. Greisen G: Surfactant administration and the cerebral circulation. Biol Neonate 1992:61: 31-36.
11. Rev M. Scgerer H. Kiessling C. Obladcn M: Surfactant bolus instillation: Effects of different doses on blood pressure and cerebral blood flow velocities. Biol Neonate 1994: 66:16-21.
12. Van de Bor M, Ma E, Walther F: Cerebral blood flow velocity after surfactant instillation in preterm infants. J Pediatr 1991:118:285-287.
13. Obladen M, Kampmann W, Zimmermann I, Lachmann B: Artificial surfactant in preterm rabbits with and without respiratory distress syndrome: Difference of in vitro and in vivo activities. Eur J Pediatr 1985: 144:195-199.
14. Damas J. Rcmaclc-Volon G. Bourdon V: Platelet-activating factor and the vascular effects of zymosan in rats. Eur J Pharmacol 1993:231: 231-236.
15. McManus L. Hanahan D. Dcmo-poulos C. Pinckard R: Palhobiology of the intravenous infusion of acetyl glyceryl ether phosphorvlcholine. a synthetic platelet-activating factor, in the rabbit. J Immunol 1980:124: 2919-2924.
16. Muacevic G, Heuer H: Platelet-activating factor antagonists in experimental shock. Arzncimiitelfor-schung 1992:42:1001-1004.
17. Robertson D. Wang D. Lee C. Levi R: Negative inotropic effect of platelet-activating factor: Association with a decrease in intracellular sodium activity. J Pharmacol Exp Ther 1988:245:124-128.
18. Yamanaka S. Miura K. Yukimura T. Okumura M. Yamamoto K: Putative mechanism of hypotensive action of platelet-activating factor in dogs. Circ Res 1992;70:893-901.
19. Moya F. Hoffman D. Zhao B. Johnston J: Platelet activating factor in surfactant preparations. Lancet 1995:341:858-860.
20. Kumar R. King RJ. Hanahan DJ: Unpublished observations: in Winslow CM. Lee ML (eds): New Horizons in Platelet Activating Factor Research. New York. Wiley. 1987. p 97.
21. Bossant M. Ninio E. Delaulier E. Bcnveniste J: Bioassay of pafacelher by rabbit platelet aggregation. Methods Enzymol 1990:187:125-130.
22. Lachmann B, Robertson B, Vogel J: In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anaesthesiol Scand 1980:24:231-236.
23. Harris J, Jackson FJ, Moxley M, Longraore W: Effect of exogenous surfactant instillation on experimental acute lung injury. J Appl Physiol 1989:66:1846-1851.
24. Engstrom P. Holm B. Matalon S: Surfactant replacement attenuates the increase in alveolar permeability in hyperoxia. J Appl Physiol 1989: 67:688-693.
25. Lewis J. Jobe A: Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993:147:218-233.
26. Seeger W. Grube C. Gunther A. Schmidt R: Surfactant inhibition by plasma proteins: Differential sensitivity of various surfactant preparations. Eur Respir J 1993:6:971-977.
27. Gross N. Smith D: Impaired surfactant phospholipid metabolism in hyperox ic mouse lungs. J Appl Physiol 1981:51:1198-1203.
28. Matalon S. Egan E: Effects of 100% O; breathing on permeability of alveolar epithelium to solute. J Appl Physiol 1981:50:859-863.
29. Strohmaicr W. Redl I I. Schlag G: Studies of the potential role of a semisynthetic surfactant preparation in an experimental aspiration trauma in rabbits. Exp Lung Res 1990:16:101-110.
30. Gilliard N. Richman P. Merritt T. Spragg R: Effect of volume and dose on the pulmonary distribution of exogenous surfactant administered to normal rabbits or to rabbits with oleic acid lung injury. Am Rev Respir Dis 1990:141:743-747.
31. Winter I. Scott J. Oulton M. Stinson D. Allen A: Autoradiographic localization and effects of exogenous ra-dioactively labelled surfactant in the lung of the prematurely delivered fetal rabbit. Biol Neonate 1991:60: 292-302.
32. Vilstrup C, Gommcrs D, Bos J, Lachmann B, Werner O, Larsson A: Natural surfactant instilled in premature lambs increases lung volume and improves ventilation homogeneity within five minutes. Pediatr Res 1992:32:595-599.
33. C'lyman R. Jobe A. Heymann M. Ikcgami M. Roman C. Payne B. Mauray F: Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 1982:100:101-107.
34. Goldsmith J. Karotkin E: Assisted Ventilation of the Neonate. Philadelphia. Saunders. 1981. pp 170-171.
35. Heuer HO: Pharmacology of hctra-zepines as PAF antagonists: in Braquet P (ed): Handbook of PAF and PAF antagonists. Boca Raton. CRC Press. 1991. pp 171-202.
36. Heuer H, Casals-Stenzel J, Muaccvic G, Weber K: Pharmacologic activity of Bepafant (WEB 2170). a new and selective hetrazepinoic antagonist of platelet-activating factor. J Pharmacol Exp Ther 1990:255: 962-968.